INHIBITION OF TYPE 3 3 alpha -HYDROXYSTEROID DEHYDROGENASE

摘要

Novel methods of treating and/or inhibiting development of prostatic cancer, benign prostatic hyperplasia, prostatitis, acne, seborrhea, hirsutism or androgenic alopecia utilize inhibitors of type 3 3 alpha -hydroxysteroid dehydrogenase alone or in combination with other active pharmaceuticals such as inhibitors of type 5 17 beta -hydroxysteroid dehydrogenase. Novel inhibitors and pharmaceutical products are also disclosed.